Shyft Analytics has raised $12.5 million in a Series B round led by Medidata and the VC wing of McKesson.
Otsuka Pharmaceutical is looking to banish paper from clinical trials by working to prepare a 100% e-platform for use in Phase III.
Apple has bought three-year-old startup Gliimpse to build out its health data capabilities.
Researchers at MIT have developed a framework to ensure genetic data can be shared freely without putting individuals’ privacy at risk.
Illumina has tasked FlowJo with developing data analysis software to support its expansion into high-throughput sequencing of single cells.
Stanford Medicine has picked Google Genomics to power its healthcare data science drive.
AstraZeneca has teamed up with Repositive to share molecular data from patient-derived xenografts.
Florence Healthcare has picked up seed funding to help clinical trial sites switch from paper files to the cloud.
Immuno-oncology upstart Forty Seven has tapped Medidata for technology as it gears up for two early-stage clinical trials.
The Garvan Institute has founded a whole genome sequencing subsidiary, given it access to an Illumina HiSeq X Ten and tapped DNAnexus for its cloud platform.